Parnax Lab

Parnax Lab Retained Earnings

The Retained Earnings of Parnax Lab (506128.BO) as of Nov 14, 2026 is 619.48 M INR. In the previous year, Retained Earnings was 504.29 M INR — a change of 22.84% (higher).

Retained Earnings

619.48 MINR

YoY

22.84%

Last updated:

Retained Earnings of Parnax Lab is 2025 619.48 M INR. Retained Earnings of Parnax Lab was 2024 504.29 M INR. It decreases by 22.84% higher compared to the previous year.

The Parnax Lab Retained Earnings history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Retained Earnings
Date
Retained Earnings
Jan 1, 2018
240.07 M INR
Jan 1, 2019
272.26 M INR
Jan 1, 2020
242.90 M INR
Jan 1, 2021
240.39 M INR
Jan 1, 2022
383.72 M INR
Jan 1, 2023
408.20 M INR
Jan 1, 2024
504.29 M INR
Jan 1, 2025
619.48 M INR
The Parnax Lab Retained Earnings history
YEARRetained EarningsYoY
619.48 MINR+22.84%
504.29 MINR+23.54%
408.20 MINR+6.38%
383.72 MINR+59.62%
240.39 MINR-1.03%
242.90 MINR-10.78%
272.26 MINR+13.41%
240.07 MINR+6.44%
225.54 MINR+18.87%
189.73 MINR+15.18%
164.72 MINR+34.73%
122.26 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

Retained Earnings of Parnax Lab is 619.48 M INR in 2025.

Retained Earnings of Parnax Lab changed from 504.29 M INR to 619.48 M INR, representing a 22.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Retained Earnings Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

Retained earnings are the cumulative net income kept in the business rather than paid out as dividends. They fund future growth and operations.

Retained Earnings's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Retained Earnings's Parnax Lab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Parnax Lab

All Key Metrics — Parnax Lab